Thermo Fisher Scientific Inc. [TMO] stock is trading at $577.39, up 0.49%. An important factor to consider is whether the stock is rising or falling in short-term value. The TMO shares have gain 5.51% over the last week, with a monthly amount glided 0.67%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Previously, Barclays downgraded its rating to Equal Weight on January 24, 2024, and elevated its price target to $555. On January 08, 2024, downgrade downgraded it’s rating to Mkt Perform. HSBC Securities started tracking the stock assigning a Buy rating and suggested a price target of $610 on December 18, 2023. Wolfe Research initiated its recommendation with a Outperform and recommended $575 as its price target on December 13, 2023. KeyBanc Capital Markets downgraded its rating to Sector Weight for this stock on October 26, 2023. In a note dated October 25, 2023, Wells Fargo upgraded an Equal Weight rating on this stock and boosted its target price from $52 to $475.
Thermo Fisher Scientific Inc. [TMO] stock has fluctuated between $415.60 and $603.82 over the past year. Currently, Wall Street analysts expect the stock to reach $641.39 within the next 12 months. Thermo Fisher Scientific Inc. [NYSE: TMO] shares were valued at $577.39 at the most recent close of the market. An investor can expect a potential return of 11.08% based on the average TMO price forecast.
Analyzing the TMO fundamentals
Thermo Fisher Scientific Inc. [NYSE:TMO] reported sales of 42.86B for the trailing twelve months, which represents a drop of -4.93%. Gross Profit Margin for this corporation currently stands at 0.41% with Operating Profit Margin at 0.16%, Pretax Profit Margin comes in at 0.15%, and Net Profit Margin reading is 0.14%. To continue investigating profitability, this company’s Return on Assets is posted at 0.06, Equity is 0.13 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.78.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 566.26 points at the first support level, and at 555.13 for the second support level. However, for the 1st resistance point, the stock is sitting at 587.49, and for the 2nd resistance point, it is at 597.59.
Thermo Fisher Scientific Inc. [TMO] reported earnings per share of $5.67 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $5.64/share, meaning a difference of $0.03 and a surprise factor of 0.50%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were $5.69 per share as compared to estimates of $5.61 per share, a difference of $0.08 representing a surprise of 1.40%.
Ratios To Look Out For
For context, Thermo Fisher Scientific Inc.’s Current Ratio is 1.75. On the other hand, the Quick Ratio is 1.39, and the Cash Ratio is 0.39. Considering the valuation of this stock, the price to sales ratio is 5.14, the price to book ratio is 4.78 and price to earnings (TTM) ratio is 37.37.
Transactions by insiders
Recent insider trading involved CASPER MARC N, Chairman & CEO, that happened on Mar 13 ’24 when 10000.0 shares were sold. Sr. VP and Chief HR Officer, Britt Lisa P. completed a deal on Mar 12 ’24 to sell 14345.0 shares. Meanwhile, Chairman & CEO CASPER MARC N sold 10000.0 shares on Mar 12 ’24.
